More News

25 Jun 2019 Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies
25 Jun 2019 Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis
21 Jun 2019 Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research Institute to Develop SPR720 for Tuberculosis
20 Jun 2019 Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
20 Jun 2019 Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases
20 Jun 2019 Amgen And The Institute For Protein Design (IPD) At University Of Washington Announce Unique Strategic Research Partnership
19 Jun 2019 Denovo Biopharma Receives Global Rights to a Novel Late-Stage Drug for Alzheimer's Disease from Orion Corporation for Development as a Personalized Medicine
17 Jun 2019 Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update
17 Jun 2019 Intralytix, the Eliava Foundation and Ferring Pharmaceuticals Sign Joint Collaboration Agreement for Reproductive Medicine and Women's Health Initiatives
17 Jun 2019 Pfizer to Acquire Array BioPharma
13 Jun 2019 AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease
12 Jun 2019 Sobi acquires emapalumab and related assets
11 Jun 2019 Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38
11 Jun 2019 BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan
10 Jun 2019 Merck to Acquire Tilos Therapeutics
07 Jun 2019 Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics
03 Jun 2019 Vical and Brickell Announce Merger Agreement
31 May 2019 ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for ASLAN004 From CSL
30 May 2019 Amicus Therapeutics and the University of Pennsylvania Announce Major Expansion of Gene Therapy Collaboration
30 May 2019 Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists
29 May 2019 Orchard Therapeutics, Fondazione Telethon and Ospedale San Raffaele Announce Exclusive Worldwide License Agreement for the Treatment of MPS-I
29 May 2019 Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics
29 May 2019 Ziopharm Oncology Announces Exclusive License with National Cancer Institute to Identify and Use T-Cell Receptors Targeting Neoantigens for Cancer with Sleeping Beauty Platform
28 May 2019 Sensorion Announces the Signature of a Partnership Framework Agreement with Institut Pasteur on Gene Therapy Programs Targeting Hearing Loss
24 May 2019 FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma NovoTTF-100L, a Tumor Treating Fields delivery system, is the first FDA-approved mesothelioma treatment in more than 15 years In

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up